Scholl Hendrik Peterinsider trades
In SEC Form 4 filings, Scholl Hendrik Peter is listed as Chief Medical Officer of Belite Bio, Inc (BLTE). In the last 90 days, Scholl Hendrik Peter sold $82.7K of Belite Bio, Inc (BLTE) on the open market and bought none. All 8 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BLTEBelite Bio, Inc | Chief Medical Officer | 8 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-05
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BLTEBelite Bio, Inc | Oct 1 | Oct 5 | S | 200 | $163.63 | Sale −$32,725 | 14,800 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Oct 1 | Oct 5 | S | 24 | $164.64 | Sale −$3,951 | 14,776 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Oct 1 | Oct 5 | S | 120 | $165.49 | Sale −$19,859 | 14,656 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Oct 1 | Oct 5 | S | 50 | $166.44 | Sale −$8,322 | 14,606 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Oct 1 | Oct 5 | S | 78 | $167.59 | Sale −$13,072 | 14,528 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Oct 1 | Oct 5 | S | 12 | $168.21 | Sale −$2,019 | 14,516 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Oct 1 | Oct 5 | S | 14 | $169.36 | Sale −$2,371 | 14,502 | Yes | Form 4 |
| BLTEBelite Bio, Inc | Oct 1 | Oct 5 | S | 2 | $170.02 | Sale −$340 | 14,500 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.